We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$1.4B
AUM Growth
+$85.3M
Cap. Flow
-$5.39M
Cap. Flow %
-0.38%
Top 10 Hldgs %
37.41%
Holding
223
New
6
Increased
61
Reduced
104
Closed
8

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$12.2M
2
STZ icon
Constellation Brands
STZ
+$2.62M
3
GILD icon
Gilead Sciences
GILD
+$1.03M
4
NVDA icon
NVIDIA
NVDA
+$608K
5
AAPL icon
Apple
AAPL
+$545K

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Financials 11.8%
3 Communication Services 9.73%
4 Consumer Discretionary 9.61%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.76T
$15.9M 1.13%
48,195
+126
+0.3% +$38.7K
CVX icon
27
Chevron
CVX
$382B
$15.9M 1.13%
102,189
+511
+0.5% +$79.1K
XLRE icon
28
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$14.8M 1.06%
351,143
+10,518
+3% +$440K
DIS icon
29
Walt Disney
DIS
$171B
$14.7M 1.05%
128,698
-1,226
-0.9% -$144K
USB icon
30
US Bancorp
USB
$97.9B
$14.5M 1.03%
299,753
-288
-0.1% -$13.6K
GILD icon
31
Gilead Sciences
GILD
$165B
$14.4M 1.03%
130,081
-9,029
-6% -$1.03M
HON icon
32
Honeywell
HON
$76.4B
$14.4M 1.02%
72,350
+299
+0.4% +$62.5K
DUK icon
33
Duke Energy
DUK
$101B
$14.2M 1.01%
114,703
+153
+0.1% +$18.6K
VYM icon
34
Vanguard High Dividend Yield ETF
VYM
$80.8B
$14M 1%
99,389
+706
+0.7% +$97K
TRV icon
35
Travelers Companies
TRV
$81.1B
$13.8M 0.99%
49,530
+237
+0.5% +$63.5K
CRM icon
36
Salesforce
CRM
$154B
$13.1M 0.93%
55,140
+544
+1% +$137K
MRK icon
37
Merck
MRK
$322B
$12.8M 0.92%
152,947
-130
-0.1% -$10.7K
ETN icon
38
Eaton
ETN
$141B
$12.6M 0.9%
33,587
+469
+1% +$171K
TMO icon
39
Thermo Fisher Scientific
TMO
$214B
$12.4M 0.89%
25,659
+130
+0.5% +$60.5K
T icon
40
AT&T
T
$164B
$12.4M 0.88%
438,477
+4,316
+1% +$123K
BA icon
41
Boeing
BA
$169B
$12.1M 0.86%
56,019
+1,202
+2% +$271K
GS icon
42
Goldman Sachs
GS
$289B
$11.7M 0.83%
14,667
-201
-1% -$149K
MRVL icon
43
Marvell Technology
MRVL
$147B
$11M 0.79%
131,109
+1,906
+1% +$140K
NKE icon
44
Nike
NKE
$64.1B
$10.9M 0.78%
156,841
-2,967
-2% -$221K
PYPL icon
45
PayPal
PYPL
$49.9B
$10.6M 0.76%
158,667
+2,918
+2% +$206K
UNH icon
46
UnitedHealth
UNH
$382B
$10.3M 0.74%
29,890
-58
-0.2% -$17.5K
SRE icon
47
Sempra
SRE
$58.1B
$10.1M 0.72%
112,431
-1,412
-1% -$114K
MAR icon
48
Marriott International
MAR
$100B
$9.65M 0.69%
37,058
+24
+0.1% +$6.44K
CTVA icon
49
Corteva
CTVA
$60.5B
$8.93M 0.64%
132,083
+217
+0.2% +$15.7K
SLB icon
50
SLB Ltd
SLB
$72.7B
$8.93M 0.64%
259,779
-7,352
-3% -$256K

Similar funds

Stonebridge Capital Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Stonebridge Capital Advisors held 223 positions worth $1.4B, up 6.5% from $1.32B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Stonebridge Capital Advisors's Q3 2025 filing shows 6 new, 61 increased, 104 reduced and 8 closed positions. Its largest new stake was Vanguard Morningstar Growth ETF: 3,276 shares worth $262K. The largest sale was Oracle, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Stonebridge Capital Advisors's largest Q3 2025 buy was Vanguard Morningstar Growth ETF: 3,276 shares worth $262K.
  • Stonebridge Capital Advisors added most to Eli Lilly in Q3 2025, an estimated $5.96M increase.
  • Stonebridge Capital Advisors's biggest Q3 2025 reduction was Oracle, cutting an estimated $12.2M.
  • Stonebridge Capital Advisors fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q3 2025, selling an estimated $491K.
  • Stonebridge Capital Advisors's ten largest holdings make up 37% of its $1.4B portfolio in Q3 2025.
  • Stonebridge Capital Advisors opened 6 new positions and closed 8 in Q3 2025.
  • Stonebridge Capital Advisors's portfolio value rose 6.5% quarter-over-quarter to $1.4B.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.